Intervacc AB (publ) (STO:IVACC)
Sweden · Delayed Price · Currency is SEK 0.9980
-0.0120 (-1.19%)
Sep 22, 2026, 5:17 PM CET
Intervacc AB Market Cap
Intervacc AB has a market cap or net worth of 340.13 million as of September 22, 2026. Its market cap has decreased by -6.03% in one year.
Market Cap
340.13M
Enterprise Value
213.36M
Revenue
18.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
ChartMarket Cap Chart
Since April 7, 2017, Intervacc AB's market cap has increased from 85.80M to 340.13M, an increase of 296.45%. That is a compound annual growth rate of 15.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 340.13M | 8.01% |
| Dec 30, 2025 | 314.91M | 255.38% |
| Dec 30, 2024 | 88.61M | -81.52% |
| Dec 29, 2023 | 479.41M | -63.48% |
| Dec 30, 2022 | 1.31B | -50.81% |
| Dec 30, 2021 | 2.67B | 0.76% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| FluoGuide | 572.23M |
| Xspray Pharma AB | 442.87M |
| Mendus AB | 428.39M |
| Cantargia AB | 390.07M |
| Corline Biomedical AB | 371.09M |
| Sprint Bioscience AB | 311.27M |
| IRLAB Therapeutics AB | 256.68M |
| Isofol Medical AB | 237.16M |